SHG:688578 - Shanghai Allist Pharmaceuticals Co Ltd

Shanghai Allist Pharmaceutical
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2017 Q4	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	121.68M 227.0%	488M 301.0%	530.09M 8.6%	604.48M 14.0%	709.03M 17.3%	559.96M -21.0%	791M 41.3%	956.35M 20.9%	1.24B 29.6%	1.62B 30.8%	2.02B 24.5%	2.48B 23.1%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.66M 386.5%	2.94M 77.3%	5.64M 91.9%	10.54M 86.8%	16.61M 57.5%	24.63M 48.3%	31.72M 28.8%	34.96M 10.2%	48.33M 38.2%	61.44M 27.1%	77.87M 26.7%	103.43M 32.8%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	120.03M 225.5%	485.06M 304.1%	524.45M 8.1%	593.94M 13.2%	692.42M 16.6%	535.33M -22.7%	759.28M 41.8%	921.39M 21.3%	1.19B 29.3%	1.56B 31.0%	1.94B 24.4%	2.38B 22.7%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	432.76M 16.8%	528.69M 22.2%	579.62M 9.6%	629.36M 8.6%	654.25M 4.0%	697.71M 6.6%	744.73M 6.7%	850.4M 14.2%	1B 17.9%	1.2B 19.5%	1.45B 20.9%	1.65B 13.8%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	431.11M 16.4%	525.75M 22.0%	573.97M 9.2%	618.81M 7.8%	637.64M 3.0%	673.07M 5.6%	713.01M 5.9%	815.44M 14.4%	954.35M 17.0%	1.14B 19.1%	1.37B 20.5%	1.54B 12.7%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-311.08M -	-40.69M -	-49.52M -	-24.87M -	54.78M -	-137.74M -	46.27M -	105.95M 129.0%	236.61M 123.3%	422.79M 78.7%	569.93M 34.8%	836.09M 46.7%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-255.01M -	-	18.27M -	-	123.38M -	-	130.52M -	-	312.17M -	-	644.17M -	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-255.01M -	29.24M -	18.27M -37.5%	39.9M 118.3%	123.38M 209.2%	-62.7M -	130.52M -	188.07M 44.1%	312.17M 66.0%	487.02M 56.0%	644.17M 32.3%	915.35M 42.1%
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-0.64 -	0.03 -	0.04 33.3%	0.09 125%	0.27 200.0%	-0.14 -	0.29 -	0.42 44.8%	0.69 64.3%	1.08 56.5%	1.43 32.4%	2.03 42.0%
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-0.64 -	0.03 -	0.04 33.3%	0.09 125%	0.27 200.0%	-0.14 -	0.29 -	0.42 44.8%	0.69 64.3%	1.08 56.5%	1.43 32.4%	2.03 42.0%